Chimeric Antigen Receptor (CAR) T-cell therapy; a promising outlook for refractory malignancies - Letter to the Editor

J Pak Med Assoc. 2018 Sep;68(9):1288.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cell- and Tissue-Based Therapy* / economics
  • Cell- and Tissue-Based Therapy* / methods
  • Health Services Needs and Demand
  • Humans
  • Lymphoma, Non-Hodgkin / immunology
  • Lymphoma, Non-Hodgkin / therapy*
  • Pakistan
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Receptors, Chimeric Antigen / immunology*

Substances

  • Receptors, Chimeric Antigen